دورية أكاديمية

Complementary and Integrative Medicine in Pancreatic Cancer.

التفاصيل البيبلوغرافية
العنوان: Complementary and Integrative Medicine in Pancreatic Cancer.
المؤلفون: Frenkel M; Complementary and Integrative Medicine Service, Oncology Division, Rambam Health Care Campus, Haifa, Israel. frenkelm@netvision.net.il., David A; Tal Center for Integrative Medicine, Institute of Oncology, Chaim Sheba Medical Center, Ramat-Gan, Israel., Sapire K; Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hausner D; Tal Center for Integrative Medicine, Institute of Oncology, Chaim Sheba Medical Center, Ramat-Gan, Israel.; Palliative Care Service, Chaim Sheba Medical Center, Ramat Gan, Israel.
المصدر: Current oncology reports [Curr Oncol Rep] 2023 Mar; Vol. 25 (3), pp. 231-242. Date of Electronic Publication: 2023 Feb 03.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Philadelphia, PA : Current Science, c1999-
مواضيع طبية MeSH: Integrative Medicine* , Complementary Therapies* , Pancreatic Neoplasms*, Humans ; Quality of Life/psychology ; Fatigue/therapy ; Pancreatic Neoplasms
مستخلص: Purpose of Review: Pancreatic cancer has high mortality and morbidity rates, associated with the issues of typically late diagnosis and the limited effectiveness of current treatments. Patients tend to experience multiple symptoms that can include anxiety, fear, depression, fatigue, weakness, peripheral neuropathy, and abdominal pain, which reduce quality of life (QoL) and may compromise the treatment continuum. Many of those symptoms are amenable to complementary and integrative medicine (CIM) therapies as a part of supportive and palliative care. This article reviews research findings on the beneficial effect of use of CIM modalities in regard to pancreatic cancer, with emphasis on pancreatic ductal adenocarcinoma (PDAC).
Recent Findings: Given the often-poor prognosis of the disease, patients with PDAC often seek integrative therapies to help manage the disease itself, to provide support through cancer treatment and its symptoms, and to provide emotional stress relief. Data is accumulating in the past few years on the potential benefits of CIM to the management of pancreatic cancer symptoms and treatment side effects, in order to augment supportive care. This data reveal that nutrition counselling; digestive enzyme therapy; microbiome support; dietary supplements; lifestyle interventions (physical activity and circadian health/sleep hygiene) appear to improve QoL of these patients through reduced symptom burden and meeting psychological needs, such as distress and fatigue. Acupuncture, mindfulness, yoga, reflexology, massage, and homeopathy may also contribute to symptom reduction, both physical and psychological, in all stages of the disease. There is supporting evidence that some CIM modalities may alleviate side effects and symptoms related to pancreatic cancer and its treatment, suggesting that practitioners might consider integrating these modalities in certain situations encountered in the treatment of pancreatic cancer. Further investigation is needed to define the optimal integration of CIM into the treatment and supportive care of patients affected by pancreatic cancer.
(© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
فهرسة مساهمة: Keywords: Acupuncture; Complementary medicine; Curcumin; Dietary supplements; Homeopathy; Integrative medicine; Mind–body medicine; Nutrition; Nutritional supplements; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Physical activity; Reflexology; Touch therapies
تواريخ الأحداث: Date Created: 20230203 Date Completed: 20230224 Latest Revision: 20231213
رمز التحديث: 20231215
DOI: 10.1007/s11912-023-01370-z
PMID: 36735141
قاعدة البيانات: MEDLINE
الوصف
تدمد:1534-6269
DOI:10.1007/s11912-023-01370-z